Avalo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.About AVTX
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders.
CEOGarry Arthur Neil
CEOGarry Arthur Neil
Employees19
Employees19
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2011
Founded2011
Employees19
Employees19
AVTX Key Statistics
Market cap15.12M
Market cap15.12M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume110.53K
Average volume110.53K
High today$16.32
High today$16.32
Low today$13.65
Low today$13.65
Open price$13.95
Open price$13.95
Volume160.83K
Volume160.83K
52 Week high$1,130.40
52 Week high$1,130.40
52 Week low$3.95
52 Week low$3.95